Cancer gene therapy by IL-12 gene delivery using liposomal bubbles and tumoral ultrasound exposure

Journal of Controlled Release

Volumn 142, Issue 2, 2010, Pages 245-250

  Suzuki, Ryo ^a   Namai, Eisuke ^a   Oda, Yusuke ^a   Nishiie, Norihito ^a   Otake, Shota ^a   Koshima, Risa ^a   Hirata, Keiichi ^a   Taira, Yuichiro ^a   Utoguchi, Naoki ^a   Negishi, Yoichi ^b   Nakagawa, Shinsaku ^c   Maruyama, Kazuo ^a  

^a TEIKYO UNIVERSITY   (Japan)

^b TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Cancer gene therapy; Interleukin 12 (IL 12); Liposomes; Non viral vector; Ultrasound

Indexed keywords

BUBBLE LIPOSOMES; CANCER CELLS; CANCER GENE THERAPY; GENE DELIVERY; GENE DELIVERY SYSTEMS; IMMUNE SYSTEMS; IN-VIVO; INTERLEUKIN-12; INTERLEUKIN-12 (IL-12); NON-INVASIVE; NON-VIRAL GENE DELIVERY; NONVIRAL VECTORS; PERFLUOROPROPANE; PLASMID DNA; SONOPORATION; T CELLS; T LYMPHOCYTES; THERAPEUTIC EFFECTS; TUMOR GROWTH; TUMOR TISSUES; ULTRASOUND EXPOSURE; ULTRASOUND IMAGING;

ACOUSTIC WAVES; GENE EXPRESSION; GENE TRANSFER; LIPOSOMES; PHOSPHOLIPIDS; TUMORS; ULTRASONIC APPLICATIONS; ULTRASONIC TRANSMISSION; ULTRASONICS;

GENE THERAPY;

INTERLEUKIN 12; LIPOSOME; LUCIFERASE; PERFLUTREN; PLASMID DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER GENE THERAPY; CANCER INHIBITION; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LYMPHOCYTE MIGRATION; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; OVARY CARCINOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOLID TUMOR; ULTRASOUND;

ANIMALS; CARCINOMA; DNA; FEMALE; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; INTERLEUKIN-12; LIPOSOMES; MICE; MICE, INBRED BALB C; MICE, NUDE; OVARIAN NEOPLASMS; PLASMIDS; TRANSFECTION; ULTRASONICS;

EID: 76749124734     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2009.10.027     Document Type: Article

References (34)

1. Gubler U., Chua A.O., Schoenhaut D.S., Dwyer C.M., McComas W., Motyka R., Nabavi N., Wolitzky A.G., Quinn P.M., Familletti P.C. Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc Natl Acad Sci U S A 1991, 88:4143-4147.
2. Wolf S.F., Temple P.A., Kobayashi M., Young D., Dicig M., Lowe L., Dzialo R., Fitz L., Ferenz C., Hewick R.M. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol 1991, 146:3074-3081.
3. Brunda M.J. Interleukin-12. J Leukoc Biol 1994, 55:280-288.
4. Nastala C.L., Edington H.D., McKinney T.G., Tahara H., Nalesnik M.A., Brunda M.J., Gately M.K., Wolf S.F., Schreiber R.D., Storkus W.J. Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production. J Immunol 1994, 153:1697-1706.
5. Yu W.G., Ogawa M., Mu J., Umehara K., Tsujimura T., Fujiwara H., Hamaoka T. IL-12-induced tumor regression correlates with in situ activity of IFN-gamma produced by tumor-infiltrating cells and its secondary induction of anti-tumor pathways. J Leukoc Biol 1997, 62:450-457.
6. Atkins M.B., Robertson M.J., Gordon M., Lotze M.T., DeCoste M., DuBois J.S., Ritz J., Sandler A.B., Edington H.D., Garzone P.D., Mier J.W., Canning C.M., Battiato L., Tahara H., Sherman M.L. Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies. Clin Cancer Res 1997, 3:409-417.
7. Leonard J.P., Sherman M.L., Fisher G.L., Buchanan L.J., Larsen G., Atkins M.B., Sosman J.A., Dutcher J.P., Vogelzang N.J., Ryan J.L. Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production. Blood 1997, 90:2541-2548.
8. Colombo M.P., Vagliani M., Spreafico F., Parenza M., Chiodoni C., Melani C., Stoppacciaro A. Amount of interleukin 12 available at the tumor site is critical for tumor regression. Cancer Res 1996, 56:2531-2534.
9. Gao J.Q., Sugita T., Kanagawa N., Iida K., Eto Y., Motomura Y., Mizuguchi H., Tsutsumi Y., Hayakawa T., Mayumi T., Nakagawa S. A single intratumoral injection of a fiber-mutant adenoviral vector encoding interleukin 12 induces remarkable anti-tumor and anti-metastatic activity in mice with Meth-A fibrosarcoma. Biochem Biophys Res Commun 2005, 328:1043-1050.
10. Gao Y., Xu Z., Chen S., Gu W., Chen L., Li Y. Arginine-chitosan/DNA self-assemble nanoparticles for gene delivery: in vitro characteristics and transfection efficiency. Int J Pharm 2008, 359:241-246.
11. Hatakeyama H., Akita H., Kogure K., Oishi M., Nagasaki Y., Kihira Y., Ueno M., Kobayashi H., Kikuchi H., Harashima H. Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid. Gene Ther 2007, 14:68-77.
12. Montier T., Benvegnu T., Jaffres P.A., Yaouanc J.J., Lehn P. Progress in cationic lipid-mediated gene transfection: a series of bio-inspired lipids as an example. Curr Gene Ther 2008, 8:296-312.
13. Morille M., Passirani C., Vonarbourg A., Clavreul A., Benoit J.P. Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. Biomaterials 2008, 29:3477-3496.
14. Fechheimer M., Boylan J.F., Parker S., Sisken J.E., Patel G.L., Zimmer S.G. Transfection of mammalian cells with plasmid DNA by scrape loading and sonication loading. Proc Natl Acad Sci U S A 1987, 84:8463-8467.
15. Miller M.W., Miller D.L., Brayman A.A. A review of in vitro bioeffects of inertial ultrasonic cavitation from a mechanistic perspective. Ultrasound Med Biol 1996, 22:1131-1154.
16. Newman C.M., Bettinger T. Gene therapy progress and prospects: ultrasound for gene transfer. Gene Ther 2007, 14:465-475.
17. Shen Z.P., Brayman A.A., Chen L., Miao C.H. Ultrasound with microbubbles enhances gene expression of plasmid DNA in the liver via intraportal delivery. Gene Ther 2008, 15:1147-1155.
18. Taniyama Y., Tachibana K., Hiraoka K., Namba T., Yamasaki K., Hashiya N., Aoki M., Ogihara T., Yasufumi K., Morishita R. Local delivery of plasmid DNA into rat carotid artery using ultrasound. Circulation 2002, 105:1233-1239.
19. Suzuki R., Takizawa T., Negishi Y., Hagisawa K., Tanaka K., Sawamura K., Utoguchi N., Nishioka T., Maruyama K. Gene delivery by combination of novel liposomal bubbles with perfluoropropane and ultrasound. J Control Release 2007, 117:130-136.
20. Suzuki R., Takizawa T., Negishi Y., Utoguchi N., Sawamura K., Tanaka K., Namai E., Oda Y., Matsumura Y., Maruyama K. Tumor specific ultrasound enhanced gene transfer in vivo with novel liposomal bubbles. J Control Release 2008, 125:137-144.
21. Suzuki R., Oda Y., Utoguchi N., Namai E., Taira Y., Okada N., Kadowaki N., Kodama T., Tachibana K., Maruyama K. A novel strategy utilizing ultrasound for antigen delivery in dendritic cell-based cancer immunotherapy. J Control Release 2009, 133:198-205.
22. Yamashita T., Sonoda S., Suzuki R., Arimura N., Tachibana K., Maruyama K., Sakamoto T. A novel bubble liposome and ultrasound-mediated gene transfer to ocular surface: RC-1 cells in vitro and conjunctiva in vivo. Exp Eye Res 2007, 85:741-748.
23. Negishi Y., Endo Y., Fukuyama T., Suzuki R., Takizawa T., Omata D., Maruyama K., Aramaki Y. Delivery of siRNA into the cytoplasm by liposomal bubbles and ultrasound. J Control Release 2008, 132:124-130.
24. K. Un, S. Kawakami, R. Suzuki, K. Maruyama, F. Yamashita, M. Hashida. Enhanced transfection efficiency into macrophages and dendritic cells by the combination method using mannosylated lipoplexes and Bubble liposomes with ultrasound exposure Hum Gene Ther. (2009) In press.
25. Hashimoto M., Niwa O., Nitta Y., Takeichi M., Yokoro K. Unstable expression of E-cadherin adhesion molecules in metastatic ovarian tumor cells. Jpn J Cancer Res 1989, 80:459-463.
26. Okada Y., Okada N., Nakagawa S., Mizuguchi H., Kanehira M., Nishino N., Takahashi K., Mizuno N., Hayakawa T., Mayumi T. Fiber-mutant technique can augment gene transduction efficacy and anti-tumor effects against established murine melanoma by cytokine-gene therapy using adenovirus vectors. Cancer Lett 2002, 177:57-63.
27. Fillat C., Carrio M., Cascante A., Sangro B. Suicide gene therapy mediated by the Herpes Simplex virus thymidine kinase gene/Ganciclovir system: fifteen years of application. Curr Gene Ther 2003, 3:13-26.
28. Shi X.H., Liang Z.Y., Ren X.Y., Liu T.H. Combined silencing of K-ras and Akt2 oncogenes achieves synergistic effects in inhibiting pancreatic cancer cell growth in vitro and in vivo. Cancer Gene Ther 2009, 16:227-236.
29. Nogawa M., Yuasa T., Kimura S., Tanaka M., Kuroda J., Sato K., Yokota A., Segawa H., Toda Y., Kageyama S., Yoshiki T., Okada Y., Maekawa T. Intravesical administration of small interfering RNA targeting PLK-1 successfully prevents the growth of bladder cancer. J Clin Invest 2005, 115:978-985.
30. Beh C.W., Seow W.Y., Wang Y., Zhang Y., Ong Z.Y., Ee P.L., Yang Y.Y. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug. Biomacromolecules 2009, 10:41-48.
31. Folini M., Pennati M., Zaffaroni N. RNA interference-mediated validation of genes involved in telomere maintenance and evasion of apoptosis as cancer therapeutic targets. Methods Mol Biol 2009, 487:303-330.
32. Lehrman S. Virus treatment questioned after gene therapy death. Nature 1999, 401:517-518.
33. Conwell C.C., Huang L. Recent advances in non-viral gene delivery. Adv Genet 2005, 53PA:1-18.
34. Kanagawa N., Gao J.Q., Motomura Y., Yanagawa T., Mukai Y., Yoshioka Y., Okada N., Nakagawa S. Antitumor mechanism of intratumoral injection with IL-12-expressing adenoviral vector against IL-12-unresponsive tumor. Biochem Biophys Res Commun 2008, 372:821-825.